SelectedWorks - Steven Johnson

Contact

Selected Works of Steven Johnson

Associate Professor of Pharmacy Practice

Steven W. Johnson is an Associate Professor at Campbell University College of Pharmacy and Health Sciences. Dr. Johnson’s practice site is at Novant Health Forsyth Medical Center where he is an Internal Medicine/Infectious Diseases Clinical Specialist. Dr. Johnson also practices in an infectious diseases clinic associated with Novant Health where he manages primarily HCV and HIV.

Works
About

×

About Steven Johnson

Steven W. Johnson is an Associate Professor at Campbell University College of Pharmacy and Health Sciences. Dr. Johnson’s practice site is at Novant Health Forsyth Medical Center where he is an Internal Medicine/Infectious Diseases Clinical Specialist. Dr. Johnson also practices in an infectious diseases clinic associated with Novant Health where he manages primarily HCV and HIV.

Present	Assistant Professor of Pharmacy Practice, Campbell University ‐ College of Pharmacy and Health Sciences
Institution Organization Position Type Position Title Time Period to Options Current Position Affiliate my profile with this Institution

Pharmacy and Pharmaceutical Sciences

Clostridium difficile infection, risk prediction models for resistant bacteria, and HCV

2018 - Present	Committee Member, On-Demand CE Webinar Committee, North Carolina Association of Pharmacists
2016 - Present	Member, American Academy of HIV Medicine
2015 - Present	Member, American College of Clinical Pharmacy
2015 - Present	Member, Research Committee, College of Pharmacy & Health Sciences, Campbell University
2015 - Present	Guest lecturer, Student Society of Health System Pharmacists
2014 - Present	Member, Continuing Education Committee, College of Pharmacy & Health Sciences, Campbell University
2014 - Present	Mentor, DeeM Residency Program
2014 - Present	Provider, HIV/HCV Clinic, Westgate Medical Office, Novant Health
2012 - Present	Member, Admissions & Enrollment Committee, College of Pharmacy & Health Sciences, Campbell University
2012 - Present	Member, American Association of Colleges of Pharmacy
2011 - Present	Member, Infectious Disease Society of America
2015 - 2018	Fundraiser, Kappa Psi
2009 - 2018	Member, American Society of Health-System Pharmacists
2013 - 2014	Member, Honors, Awards, & Scholarship Committee, College of Pharmacy & Health Sciences, Campbell University
2013 - 2014	Member, Technology Committee,College of Pharmacy & Health Sciences, Campbell University
2012 - 2014	Member, American Society of Microbiology
2013	Chair, Faculty Search Committee, College of Pharmacy & Health Sciences, Campbell University
2007 - 2011	Mentor, P1 Mentor Program University of Colorado School of Pharmacy
2009 - 2010	Member, Rho Chi Honor Society, Alpha Theta Chapter
	Member, North Carolina Association of Pharmacists

Professor of the year (P4), 2016
Professor of the year (P3), 2016
Rho Chi Honorary Invitation, 2009

2010	Pharm.D., University of Colorado, Denver ‐ Skaggs School of Pharmacy and Pharmaceutical Sciences
Institution Organization Student Type Student Title Degree Time Period to Options Currently enrolled Affiliate my profile with this Institution

Antifungal use in transplant recipients: selection, administration and monitoring (R. H. Drew, M. L. Townsend, M. W. Pound, et al.) Antifungal Therapy (2019)

Reply to McCreery et al. (S. W. Johnson, S. V. Brown and D. H. Priest) Clinical Infectious Diseases (2020)

Effectiveness of oral vancomycin for prevention of healthcare facility-onset Clostridiodes difficile infection in targeted patients during systemic antibiotic exposure (S. W. Johnson, S. V. Brown and D. H. Priest) Clinical Infectious Diseases (2020)

Impact of a pharmacist-led COPD clinic on patient outcomes in a rural healthcare clinic (S. L. Russell, B. Mills and S. W. Johnson) Journal of Contemporary Pharmacy Practice (2020)

Development of a risk prediction model for hospital-onset Clostridium difficile infection in patients receiving systemic antibiotics (C. Tilton and S. W. Johnson) American Journal of Infection Control (2019)

Evaluation of a vancomycin dosing nomogram in obese patients weighing at least 100 kilograms (R. D. Bowers, A. A. Cooper, C. L. Wente, et al.) Pharmacy Practice (2018)

Effectiveness of Ledipasvir/Sofobuvir in real-world patients with chronic hepatitis in real-world patients with chronic hepatitis C virus: A collaborative treatment approach (S. W. Johnson, S. R. Ammirati, C. E. Hartis, et al.) International Journal of Antimicrobial Agents (2017)

Cure with Ladipasvir/Sofosbuvir for chronic Hepatitis C virus in an individual with gastric bypass (S. W. Johnson, A. L. Teachey, S. M. Valanejad, et al.) J. Clin. Pharm. Ther. (2017)

Hepatitis C virus-genotype 3: update on current and emergent therapeutic interventions (S. W. Johnson, D. K. Thompson and B. Raccor) Current Infectious Disease Reports (2017)

Medication discrepancy rates among Medicaid recipients at hospital discharge (T. D. Perry, A. M. Nye and S. W. Johnson) JAPHA (2017)

Curing the historically incurable: Treatment success with Ledipasvir/Sofosbuvir for chronic Hepatitis C virus in a heavily treatment experienced individual (S. W. Johnson, M. M. Davis, L. M. Stever, et al.) J. Clin. Pharm. Ther. (2016)

Role of Isavuconazole in the treatment of invasive fungal infections (D. T. Wilson, V. P. DiMondi, S. W. Johnson, et al.) Therapeutics and Clinical Risk Management (2016)

Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections (T. M. Jones, S. W. Johnson, V. P. DiMondi, et al.) Infection and Drug Resistance (2016)

Demographic and infection characteristics of patients with carbapenem-resistant Enterobacteriaceae in a community hospital: Development of a bedside clinical score for risk assessment (S. W. Johnson and B. M. Miller) American Journal of Infection Control (2015)

Ceftaroline: Place in therapy compared to the available intravenous cephalosporins (S. W. Johnson and D. B. May) Infectious Diseases in Clinical Practice (2014)

How long to treat with antibiotics following amputation in patients with diabetic foot infections? Are the 2012 IDSA DFI guidelines reasonable? (S. W. Johnson, R. H. Drew and D. B. May) Journal of Clinical Pharmacy and Therapeutics (2013)

Recent advances in the treatment of life-threatening, invasive fungal infections (Richard H. Drew, Mary L. Townsend, Melanie W. Pound, et al.) Expert Opinion on Pharmacotherapy (2013)

Utility of a clinical risk-factor scoring model in predicting infection with Extended-Spectrum β-Lactamase (ESBL)-Producing Enterobacteriaceae upon hospital admission (S. W. Johnson, R. H. Drew, D. B. May, et al.) Pharmacy Practice (2012)

Clinical impact of switching conventional enzyme immunoassay with nucleic acid amplification test for suspected Clostridium difficile-associated diarrhea difficile Associated Diarrhea (S. W. Johnson, M. Kanatani, R. M. Humphries, et al.) American Journal of Infection Control (2011)

Posters (14)

Effectiveness of oral vancomycin for prevention of healthcare 10/2019 facility-onset Clostridiodes difficile infection in targeted patients during systemic antibiotic exposure (S. W. Johnson) Pharmacy Practice (2019)

Effectiveness of oral vancomycin for prevention of healthcare facility-onset Clostridiodes difficile infection in targeted patients during systemic antibiotic exposure (S. W. Johnson) Pharmacy Practice (2019)

Expansion of a risk prediction model for healthcare facility-onset Clostridiodes difficile infection in patients receiving systemic antibiotics (S. W. Johnson) Pharmacy Practice (2018)

Assessing the impact of a patient care management program on the rate of clinical interventions made by pharmacists at a specialty pharmacy in transplant patients (S. W. Johnson) Pharmacy Practice (2018)

Impact of a pharmacist-led education program on rates of initialpneumococcal polysaccharide-23 vaccination among vaccine-eligible adults with asthma and COPD (S. W. Johnson) Pharmacy Practice (2018)

Development of a risk prediction model for hospital-onset Clostridium difficile infection in patients receiving systemic antibiotics (S. W. Johnson) Pharmacy Practice (2017)